Connecticut House Bill HB05856

Connecticut 2019 Regular Session

• Introduced: 1/23/19
• Refer: 1/23/19

Caption

An Act Concerning Health Insurance Coverage For Psychotropic Drugs.

Impact

If passed, this bill is expected to significantly affect the way health insurance policies operate regarding prescription drug coverage, specifically for mental health medications. By eliminating the insurer's ability to impose quantity restrictions, health care providers will be better positioned to tailor prescriptions to the individual needs of their patients. This change could foster improved patient outcomes, particularly for those requiring psychotropic treatments, as it recognizes the importance of provider discretion in the management of mental health care.

Summary

House Bill 05856 is designed to amend the current statutes regarding health insurance coverage for psychotropic drugs. The primary focus of the bill is to prevent insurers and other entities involved in health care from mandating specific quantities of psychotropic medications prescribed by health care providers. This stipulation aims to give providers more flexibility to determine appropriate dosages based on their professional judgment rather than adhering to potentially restrictive insurance company protocols.

Contention

Discussions surrounding the bill may bring about points of contention related to insurance regulation and the balance of power between health care providers and insurers. Supporters of the bill, particularly mental health advocates, may argue that it addresses critical gaps in patient care and supports the autonomy of health care providers. Conversely, insurance representatives might raise concerns about potential increases in costs if providers prescribe larger quantities of medications without oversight. Such debates highlight the complexities of health coverage regulations and the ongoing challenge of ensuring access to appropriate health care while managing costs.